Zimin Shi
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RNF7-Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes.
Journal: Molecular carcinogenesis
Published: November 12, 2024
Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis.
Journal: Cancer research and treatment
Published: October 31, 2024
Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Journal: The journal of gene medicine
Published: December 10, 2023
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma.
Journal: Journal of cellular and molecular medicine
Published: February 06, 2023
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Journal: BMC cancer
Published: October 19, 2022
Systematic characterization and biological functions of non-coding RNAs in glioblastoma.
Journal: Cell proliferation
Published: August 30, 2022
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer.
Journal: Frontiers in oncology
Published: February 25, 2022
SOCS proteins and their roles in the development of glioblastoma.
Journal: Oncology letters
Published: July 29, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026